The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial
- PMID: 20687924
- PMCID: PMC2922111
- DOI: 10.1186/1471-2458-10-457
The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial
Abstract
Background: Patients with type 2 diabetes mellitus (T2DM) have an increased risk to develop severe diabetes related complications, especially cardiovascular disease (CVD). The risk to develop CVD can be estimated by means of risk formulas. However, patients have difficulties to understand the outcomes of these formulas. As a result, they may not recognize the importance of changing lifestyle and taking medication in time. Therefore, it is important to develop risk communication methods, that will improve the patients' understanding of risks associated with having diabetes, which enables them to make informed choices about their diabetes care.The aim of this study is to investigate the effects of an intervention focussed on the communication of the absolute 10-year risk to develop CVD on risk perception, attitude and intention to change lifestyle behaviour in patients with T2DM. The conceptual framework of the intervention is based on the Theory of Planned Behaviour and the Self-regulation Theory.
Methods: A randomised controlled trial will be performed in the Diabetes Care System West-Friesland (DCS), a managed care system. Newly referred T2DM patients of the DCS, younger than 75 years will be eligible for the study. The intervention group will be exposed to risk communication on CVD, on top of standard managed care of the DCS. This intervention consists of a simple explanation on the causes and consequences of CVD, and possibilities for prevention. The probabilities of CVD in 10 year will be explained in natural frequencies and visualised by a population diagram. The control group will receive standard managed care. The primary outcome is appropriateness of risk perception. Secondary outcomes are attitude and intention to change lifestyle behaviour and illness perception. Differences between baseline and follow-up (2 and 12 weeks) between groups will be analysed according to the intention-to-treat principle. The study was powered on 120 patients in each group.
Discussion: This innovative risk communication method based on two behavioural theories might improve patient's appropriateness of risk perception and attitude concerning lifestyle change. With a better understanding of their CVD risk, patients will be able to make informed choices concerning diabetes care.
Trial registration: The trial is registered as NTR1556 in the Dutch Trial Register.
Figures
Similar articles
-
Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study.Diabetes Care. 2012 Dec;35(12):2485-92. doi: 10.2337/dc11-2130. Epub 2012 Aug 24. Diabetes Care. 2012. PMID: 22923669 Free PMC article. Clinical Trial.
-
The effectiveness of adding cognitive behavioural therapy aimed at changing lifestyle to managed diabetes care for patients with type 2 diabetes: design of a randomised controlled trial.BMC Public Health. 2007 May 8;7:74. doi: 10.1186/1471-2458-7-74. BMC Public Health. 2007. PMID: 17488511 Free PMC article. Clinical Trial.
-
Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular disease risk in real life: a randomized controlled trial.Int J Behav Nutr Phys Act. 2013 Apr 19;10:47. doi: 10.1186/1479-5868-10-47. Int J Behav Nutr Phys Act. 2013. PMID: 23597082 Free PMC article. Clinical Trial.
-
The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus.Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):69-75. doi: 10.1016/j.pcad.2015.04.002. Epub 2015 Apr 30. Prog Cardiovasc Dis. 2015. PMID: 25936906 Free PMC article. Review.
-
Cardiovascular disease risk communication and prevention: a meta-analysis.Eur Heart J. 2024 Mar 27;45(12):998-1013. doi: 10.1093/eurheartj/ehae002. Eur Heart J. 2024. PMID: 38243824 Free PMC article.
Cited by
-
Assessing the Risk Perception and Knowledge Regarding Cardiovascular Diseases in Patients With Hypertension and Diabetes in Central India: A Mixed-Methods Study.Cureus. 2023 Aug 22;15(8):e43935. doi: 10.7759/cureus.43935. eCollection 2023 Aug. Cureus. 2023. PMID: 37746382 Free PMC article.
-
Risk scoring for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2017 Mar 14;3(3):CD006887. doi: 10.1002/14651858.CD006887.pub4. Cochrane Database Syst Rev. 2017. PMID: 28290160 Free PMC article.
-
A parallel-arm randomised control trial to study the effects of risk communication methods for prevention of cardiovascular diseases: EFFRICO trial.J Family Med Prim Care. 2024 May;13(5):1922-1930. doi: 10.4103/jfmpc.jfmpc_1557_23. Epub 2024 May 24. J Family Med Prim Care. 2024. PMID: 38948564 Free PMC article.
-
Do Words Matter? Health Care Providers' Use of the Term Prediabetes.Health Risk Soc. 2017;19(5-6):301-315. doi: 10.1080/13698575.2017.1386284. Epub 2017 Oct 5. Health Risk Soc. 2017. PMID: 30881200 Free PMC article.
-
Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study.Diabetes Care. 2012 Dec;35(12):2485-92. doi: 10.2337/dc11-2130. Epub 2012 Aug 24. Diabetes Care. 2012. PMID: 22923669 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials